128 related articles for article (PubMed ID: 26914155)
1. 3'-O- and 5'-O-Propargyl Derivatives of 5-Fluoro-2'-Deoxyuridine: Synthesis, Cytotoxic Evaluation and Conformational Analysis.
Baraniak D; Baranowski D; Ruszkowski P; Boryski J
Nucleosides Nucleotides Nucleic Acids; 2016; 35(4):178-94. PubMed ID: 26914155
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3'-azido-2',3'-dideoxy-5-fluorouridine phosphoramidates and evaluation of their anticancer activity.
Lewandowska M; Ruszkowski P; Baraniak D; Czarnecka A; Kleczewska N; Celewicz L
Eur J Med Chem; 2013 Sep; 67():188-95. PubMed ID: 23867603
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activity of some 5-fluoro-2'-deoxyuridine phosphoramidates.
Lewandowska M; Ruszkowski P; Chojnacka K; Kleczewska N; Hoffmann M; Kacprzak K; Celewicz L
Bioorg Med Chem; 2016 May; 24(10):2330-41. PubMed ID: 27073055
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological assay of new 2'-deoxyuridine dimers containing a 1,2,3-triazole linker. Part I.
Michalska L; Wawrzyniak D; Szymańska-Michalak A; Barciszewski J; Boryski J; Baraniak D
Nucleosides Nucleotides Nucleic Acids; 2019; 38(3):218-235. PubMed ID: 30588866
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside dimers analogs containing floxuridine and thymidine with unnatural linker groups: synthesis and cancer line studies. Part III.
Baraniak D; Ruszkowski P; Baranowski D; Framski G; Boryski J
Nucleosides Nucleotides Nucleic Acids; 2019; 38(12):980-1005. PubMed ID: 31380708
[TBL] [Abstract][Full Text] [Related]
6. 5'-O-Palmitoyl- and 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine--novel lipophilic analogues of 5'-fluoro-2'-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological results.
Schwendener RA; Supersaxo A; Rubas W; Weder HG; Hartmann HR; Schott H; Ziegler A; Hengartner H
Biochem Biophys Res Commun; 1985 Jan; 126(2):660-6. PubMed ID: 3156589
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of O-alkyl-3-N-aminoacyloxymethyl-5-fluoro-2'-deoxyuridine derivatives.
Harada N; Hongu M; Kawaguchi T; Ohohashi M; Oda K; Hashiyama T; Tsujihara K
Chem Pharm Bull (Tokyo); 1996 Jun; 44(6):1196-201. PubMed ID: 8814951
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2'-deoxyuridine and 5-fluoro-2'-deoxyuridine derivatives and evaluation in antibody targeting studies.
Henn TF; Garnett MC; Chhabra SR; Bycroft BW; Baldwin RW
J Med Chem; 1993 May; 36(11):1570-9. PubMed ID: 8496926
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside dimers analogues with a 1,2,3-triazole linkage: conjugation of floxuridine and thymidine provides novel tools for cancer treatment. Part II.
Baraniak D; Baranowski D; Ruszkowski P; Boryski J
Nucleosides Nucleotides Nucleic Acids; 2019; 38(11):807-835. PubMed ID: 31177919
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
Wu W; Borch RF
Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 5-fluoro-2'-deoxyuridine phosphoramidate analogs.
Fries KM; Joswig C; Borch RF
J Med Chem; 1995 Jul; 38(14):2672-80. PubMed ID: 7629806
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro anticancer activity of new gemcitabine-nucleoside analogue dimers containing methyltriazole or ester-methyltriazole linker.
Trznadel R; Singh A; Kleczewska N; Liberska J; Ruszkowski P; Celewicz L
Bioorg Med Chem Lett; 2019 Sep; 29(18):2587-2594. PubMed ID: 31400940
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiviral and cytotoxic activity of 2'-deoxyuridines, 2'-fluoro-2'-deoxyuridines and 2'-arabinouridines containing 5-(1-hydroxy-2-halo-2-ethoxycarbonylethyl)-, 5-(1-hydroxy-2-iodo-2- carboxyethyl)- and 5-[1-hydroxy (or methoxy)-2-iodoethyl] substituents.
Kumar R; Wiebe LI; Knaus EE; Allen TM; Tempest ML
Drug Des Discov; 1992 Feb; 8(3):179-89. PubMed ID: 1326340
[TBL] [Abstract][Full Text] [Related]
14. New 3'-O-aromatic acyl-5-fluoro-2'-deoxyuridine derivatives as potential anticancer agents.
Szymańska-Michalak A; Wawrzyniak D; Framski G; Kujda M; Zgoła P; Stawinski J; Barciszewski J; Boryski J; Kraszewski A
Eur J Med Chem; 2016 Jun; 115():41-52. PubMed ID: 26994842
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of salinomycin conjugates with floxuridine.
Huczyński A; Antoszczak M; Kleczewska N; Lewandowska M; Maj E; Stefańska J; Wietrzyk J; Janczak J; Celewicz L
Eur J Med Chem; 2015 Mar; 93():33-41. PubMed ID: 25644674
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activity of 3'-(chloroethyl)nitrosourea analogues of 2'-deoxyuridine and 2'-deoxy-5-fluorouridine.
Lin TS; Brubaker WF; Wang ZH; Park S; Prusoff WH
J Med Chem; 1986 May; 29(5):862-5. PubMed ID: 2939245
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.
Xia Z; Wiebe LI; Miller GG; Knaus EE
Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside conjugates. 8. The preparation of 5-fluoro-2'-deoxyuridine conjugates of corticosteroids.
An SH; West CR; Hong CI
Steroids; 1986 Jun; 47(6):413-20. PubMed ID: 2956735
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 2',3'-didehydro-2',3'-dideoxyinosine phosphoramidate prodrugs and evaluation of their anticancer activity.
Borek W; Lewandowska M; Kleczewska N; Ruszkowski P; Kacprzak K; Celewicz L
Nucleosides Nucleotides Nucleic Acids; 2014; 33(8):507-18. PubMed ID: 25009986
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (AZT).
Celewicz L; Jóźwiak A; Ruszkowski P; Laskowska H; Olejnik A; Czarnecka A; Hoffmann M; Hładoń B
Bioorg Med Chem; 2011 Nov; 19(21):6375-82. PubMed ID: 21945463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
